Jennifer Brown

Washington University, Saint Louis Washington University, Saint Louis, St. Louis, MO 
"Jennifer Brown"
Mean distance: 18.27 (cluster 28)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Lampson BL, Kim HT, Davids MS, et al. (2019) Efficacy results of a phase 2 trial of first-line idelalisib plus ofatumumab in chronic lymphocytic leukemia. Blood Advances. 3: 1167-1174
Davids MS, Kim HT, Nicotra A, et al. (2018) Umbralisib in combination with ibrutinib in patients with relapsed or refractory chronic lymphocytic leukaemia or mantle cell lymphoma: a multicentre phase 1-1b study. The Lancet. Haematology
Improgo MR, Tesar B, Klitgaard JL, et al. (2018) MYD88 L265P mutations identify a prognostic gene expression signature and a pathway for targeted inhibition in CLL. British Journal of Haematology
Ott CJ, Federation AJ, Schwartz LS, et al. (2018) Enhancer Architecture and Essential Core Regulatory Circuitry of Chronic Lymphocytic Leukemia. Cancer Cell
Brown J, Behnam R, Coddington L, et al. (2018) Expanding the Optogenetics Toolkit by Topological Inversion of Rhodopsins. Cell
Davids MS, Kim HT, Yu L, et al. (2018) Ofatumumab plus high dose methylprednisolone followed by ofatumumab plus alemtuzumab to achieve maximal cytoreduction prior to allogeneic transplantation for 17p deleted or TP53 mutated chronic lymphocytic leukemia. Leukemia & Lymphoma. 1-4
Brown JR, Hamadani M, Hayslip J, et al. (2018) Voxtalisib (XL765) in patients with relapsed or refractory non-Hodgkin lymphoma or chronic lymphocytic leukaemia: an open-label, phase 2 trial. The Lancet. Haematology
Aw A, Kim HT, Fernandes SM, et al. (2017) Minimal residual disease detected by immunoglobulin sequencing predicts CLL relapse more effectively than flow cytometry. Leukemia & Lymphoma. 1-4
Tiao G, Improgo MR, Tausch E, et al. (2017) Analysis of ITGB2 rare germline variants in chronic lymphocytic leukemia. Blood
Robinson BG, Bunzow JR, Grimm JB, et al. (2017) Desensitized D2 autoreceptors are resistant to trafficking. Scientific Reports. 7: 4379
See more...